Utilization of Internet-Based Survivorship Care Plans by Lung Cancer Survivors
Utilization of Internet-Based Survivorship Care Plans by Lung Cancer Survivors
复制标题
DOI：
10.3816/clc.2009.n.047
复制
发表时间：
2009-09-01
影响因子：
3.6
通讯作者：
Metz, James M.
中科院分区：
文献类型：
--
作者：
Hill-Kayser, Christine E.;Vachani, Carolyn;Metz, James M.
背景资料：肺癌后生活的人仍然是癌症幸存者人群的重要子集，他们可能面临肺癌及其治疗的严重健康后果的风险。医学研究所建议为所有癌症幸存者制定生存护理计划。材料和方法：一个程序，用于创建生存护理计划，OncoLife，公开访问。用户回答了有关人口统计学，诊断和治疗的问题，并收到了全面的，个性化的指导方针，为未来的护理解决问题，如晚期毒性，第二恶性肿瘤，生育能力和肿瘤复发。经机构审查委员会批准，数据以匿名方式保存。结果：从2007年5月到2008年11月，3343人完成了OncoLife调查。肺癌幸存者占4%（n = 142），诊断时的中位年龄为57岁，目前的中位年龄为59岁。肺癌幸存者中50%为男性，83%为白人。78%的肺癌患者使用化疗，58%使用放疗，38%使用手术。大多数肺癌幸存者（62%）报告仅接受肿瘤科医生的后续护理，而27%的人报告由初级保健提供者（PCP）和肿瘤科医生进行监测，6%的人只接受PCP。只有11%的人报告在治疗结束时收到了生存信息。结论：OncoLife是第一个基于网络的创建生存护理计划的项目，肺癌幸存者似乎愿意使用这种工具。大多数人接受了多模式护理，使他们面临与治疗有关的晚期效应的风险。大多数幸存者没有报告接受PCP的常规护理，因此肿瘤学界对幸存者医疗保健需求的关注尤为重要。
Background: Persons living after lung cancer remain an important subset of the cancer survivor population who may be at risk for serious health consequences of lung cancer and its treatments. The Institute of Medicine recommends survivorship care plans for all cancer survivors. Materials and Methods: A program for the creation of survivorship care plans, OncoLife, was made publicly accessible. Users responded to queries regarding demographics, diagnosis, and treatment and received comprehensive, individualized guidelines for future care addressing issues such as late toxicity, second malignancy, fertility, and tumor recurrence. Data were maintained anonymously with approval from the Institutional Review Board. Results: From May 2007 to November 2008, 3343 individuals completed OncoLife surveys. Lung cancer survivors comprised 4% (n = 142), with a median age at diagnosis of 57 years and median current age of 59 years. Lung cancer survivors were 50% male and 83% Caucasian. Chemotherapy was used in the treatment of 78% of patients with lung cancer, radiation was used in 58%, and surgery was used in 38%. Most lung cancer survivors (62%) reported receiving follow-up care from only an oncologist, while 27% reported being monitored by a primary care provider (PCP) and an oncologist, and 6% saw only a PCP. Only 11% reported receiving survivorship information at the conclusion of therapy. Conclusion: OncoLife represents the first Web-based program for the creation of survivorship care plans, and lung cancer survivors appear willing to use this type of tool. Most have received multimodality care, placing them at risk for treatment-related late effects. Most survivors do not report receiving routine care from a PCP, so attention to survivor healthcare needs by the oncology community is particularly important.